OTC drugs
Johnson & Johnson Inc: OTC Healthcare
| Publication Date | January 2007 |
| Publisher | Euromonitor International |
| Product Type | Report |
| Pages | 38 |
| ISBN Number | not applicable |
| Product Code | EUR00824 |
Summary
This Johnson & Johnson Inc Company Profile offers detailed strategic analysis of the company's business, examining its performance in the OTC healthcare industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Contents
- Johnson & Johnson Inc (OTC Healthcare)Strategic Evaluation
- Swot analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
- Prospects for The OTC Healthcare Business
- Upward market trends in OTC healthcare
- Analgesics and cough, cold and allergy remedies - continued value potential
- Medicated skin care portfolio to benefit from acne treatment brands
- Bleak prospects for digestive remedies overall but diarrhoeals show potential
- Mixed fortunes for wound treatments
- Niche markets performing strongly
- Further potential in child-specific OTC healthcare
- Rx-to-OTC switches boost growth opportunities
- Corporate Overview
- Strategic Objectives and Challenges
- Operational and Distribution Strategies
- Ownership Events
- Pipeline
- Performance by Region and by Sector
- OTC Healthcare Market Assessment
- Analgesics
- Competitive landscape
- Prospects
- Cough, Cold and Allergy (hay Fever) Remedies
- Competitive landscape
- Prospects
- Medicated Skin Care
- Competitive landscape
- Prospects
- Digestive Remedies
- Competitive landscape
- Prospects
- Wound Treatments
- Competitive landscape
- Prospects
- OTC Statins
- Competitive landscape
- Prospects
- Eye Care/ear Care/adult Mouthcare/vitamins and Dietary Supplements/calming & Sleeping Products
- Competitive landscape
- Prospects
- Brand Assessment
- Brand Strategy
- Band-aid
- Clean & Clear
- Imodium
- Monistat
- Neutrogena
- Tylenol
- Appendices
- Financial Summary
- Company Background
- List of Summaries
- Summary 1 Johnson & Johnson Inc: Key Facts by Value
- Summary 2 Johnson & Johnson Inc: Historical Development
- Summary 3 Johnson & Johnson Inc: Subsidiaries 2005
- Summary 4 Johnson & Johnson Inc: OTC Healthcare Brands 2005
- Summary 5 Johnson & Johnson Inc: Company Locations
- Summary 6 Johnson & Johnson Inc: Websites
- List of Tables
- Table 1 Johnson & Johnson Inc: World Sector Sales Performance by Value 2005
- Table 2 Johnson & Johnson Inc: OTC Healthcare Regional Sales Performance by Value 2005
- Table 3 Johnson & Johnson Inc: World Shares & Rankings in OTC Healthcare by Sector by Value 2004- 2005
- Table 4 Johnson & Johnson Inc: World and Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 5 Johnson & Johnson Inc: Band-Aid Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 6 Johnson & Johnson Inc: Band-Aid Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 7 Johnson & Johnson Inc: Clean & Clear Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 8 Johnson & Johnson Inc: Clean & Clear Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 9 Johnson & Johnson Inc: Imodium Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 10 Johnson & Johnson Inc: Imodium Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 11 Johnson & Johnson Inc: Monistat Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 12 Johnson & Johnson Inc: Monistat Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 13 Johnson & Johnson Inc: Neutrogena Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 14 Johnson & Johnson Inc: Neutrogena Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 15 Johnson & Johnson Inc: Tylenol Brand Shares in OTC Healthcare by Sector by Value 2004-2005
- Table 16 Johnson & Johnson Inc: Tylenol Regional Shares in OTC Healthcare by Sector by Value 2005
- Table 17 Johnson & Johnson Inc: Financial Summary 2001-2005







